REVA Medical Announces Successful MOTIV® Live Case Demonstration and Late-Breaking BTK Trial Results at VIVA26

ConferencepositiveMOTIVPositive

AI Analysis

Summary

REVA Medical announced successful live case demonstration and late-breaking BTK trial results at VIVA26, showing higher efficacy endpoint rates with MOTIV scaffolds compared to balloon angioplasty in Rutherford 4 and 5 CLTI populations.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Live case demonstration of successful below-the-knee revascularization with MOTIV scaffolds; late-breaking BTK trial results showed higher efficacy endpoint rates with MOTIV versus balloon angioplasty in both Rutherford 4 and Rutherford 5 CLTI populations

Importance:6/10

Sentiment:

0.75

BTKCLTIcardiovascularmedical devicescaffoldlate-breaking dataconference presentation

Related Companies

$MDCE

Read the original article

Published by PR Newswire Biotech on October 6, 2026 3:44 PM

Read Original